BCG Plus Interferon Alfa 2b in Treating Patients With Bladder Cancer
Clinical trial NCT00004122 · COMPLETED
Trial details
- NCT number
- NCT00004122
- Sponsor
- Roswell Park Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 1999-07-01
- Primary completion
- 2001-04-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.